Dr Andrea Schaffer

PhD, University of New South Wales, Australia (2017)

MBiostat, University of Sydney, Australia (2011)

MSc(Epidemiology), McGill University, Canada (2004)

BSc(Hons)(Microbiology and Immunology), McGill University, Canada (2001)

Medicine & Health

School of Population Health

ResearchGate

Google Scholar

Twitter

E-mail

andrea.schaffer@unsw.edu.au

Location

Centre for Big Data Research Level 2, AGSM Building (G27)

Book Chapters | 2012

Roach ; Williams G; Hor M; Ramraj V, 2012, 'Introduction', in Ramraj V; Hor M; Roach K (ed.), Global Anti-Terrorism Law and Policy, Cambridge University Press, UK, pp. 1 - 17
Journal articles | 2023

Carland JE; Stacy AE; Schaffer AL; Day RO; Brett J; Reuter SE; Stocker SL, 2023, 'Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin', British Journal of Clinical Pharmacology, 89, pp. 1896 - 1902, http://dx.doi.org/10.1111/bcp.15668

Journal articles | 2023

Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL, 2023, 'Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data', Medical Journal of Australia, 219, pp. 63 - 69, http://dx.doi.org/10.5694/mja2.51985

Journal articles | 2023

Chitty KM; Sperandei S; Carter GL; Ali Z; Raubenheimer JE; Schaffer AL; Page A; Buckley NA, 2023, 'Five healthcare trajectories in the year before suicide and what they tell us about opportunities for prevention: a population-level case series study', eClinicalMedicine, 63, http://dx.doi.org/10.1016/j.eclinm.2023.102165

Journal articles | 2023

Costa JDO; Lin J; Pearson SA; Buckley NA; Schaffer AL; Falster MO, 2023, 'Persistence and Adherence to Cardiovascular Medicines in Australia', Journal of the American Heart Association, 12, pp. e030264, http://dx.doi.org/10.1161/JAHA.122.030264

Journal articles | 2023

Costello RE; Tazare J; Piehlmaier D; Herrett E; Parker EPK; Zheng B; Mansfield KE; Henderson AD; Carreira H; Bidulka P; Wong AYS; Warren-Gash C; Hayes JF; Quint JK; MacKenna B; Mehrkar A; Eggo RM; Katikireddi SV; Tomlinson L; Langan SM; Mathur R; LH&W NCS (or CONVALESCENCE) Collaborative ; OpenSAFELY collaborative , 2023, 'Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform.', EClinicalMedicine, 61, pp. 102077, http://dx.doi.org/10.1016/j.eclinm.2023.102077

Journal articles | 2023

Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159

Journal articles | 2023

Lim JS; Buckley NA; Cairns R; Schumann J; Schaffer AL; Chitty KM, 2023, 'Substances Detected During Coroner Postmortem Toxicology Analyses in Poisoning- and Nonpoisoning-Related Suicides.', JAMA Psychiatry, http://dx.doi.org/10.1001/jamapsychiatry.2023.2289

Journal articles | 2023

Meier MH; Meier MA; Anderson SF; Schaffer AL; Waddell JT; Roman BA; Poling SL; Barton EA, 2023, 'The effects of the 4/20 cannabis holiday and adult-use cannabis legalization on medical cannabis sales and medical cannabis patient registration in Arizona', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103974

Journal articles | 2023

Schaffer AL; Gisev N; Blyth FM; Buckley NA; Currow D; Dobbins TA; Wilson A; Degenhardt L; Pearson SA, 2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481, http://dx.doi.org/10.1111/dar.13675

Journal articles | 2023

de Oliveira Costa J; Lau S; Medland N; Gibbons S; Schaffer AL; Pearson SA, 2023, 'Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia', British Journal of Clinical Pharmacology, 89, pp. 1541 - 1553, http://dx.doi.org/10.1111/bcp.15614

Journal articles | 2022

Camacho X; Schaffer A; Buckley N; Pratt N; Brett J; Henry D; Pearson S-A, 2022, 'Trends in dispensing and utilisation of sustained-release tapentadol in Australia.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1978

Journal articles | 2022

Camacho X; Zoega H; Gomes T; Schaffer AL; Henry D; Pearson S-A; Vigod S; Havard A, 2022, 'The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions.', International Journal of Epidemiology, 52, pp. 190 - 202, http://dx.doi.org/10.1093/ije/dyac180

Journal articles | 2022

Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378, http://dx.doi.org/10.1002/pds.5395

Journal articles | 2022

Falster MO; Schaffer AL; Wilson A; Nasis A; Jorm LR; Hay M; Leeb K; Pearson SA; Brieger D, 2022, 'Evidence-practice gaps in P2Y12 inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population-level data linkage in Australia', Internal Medicine Journal, 52, pp. 249 - 258, http://dx.doi.org/10.1111/imj.15036

Journal articles | 2022

Gillies MB; Burgner DP; Ivancic L; Nassar N; Miller JE; Sullivan SG; Todd IMF; Pearson SA; Schaffer AL; Zoega H, 2022, 'Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship', British Journal of Clinical Pharmacology, 88, pp. 1143 - 1151, http://dx.doi.org/10.1111/bcp.15000

Journal articles | 2022

Murnion B; Schaffer A; Cairns R; Brett J, 2022, 'Gabapentinoids: repeating mistakes of the past?', Addiction, http://dx.doi.org/10.1111/add.15970

Journal articles | 2022

Schaffer AL; Bruno C; Buckley NA; Cairns R; Litchfield M; Paget S; Zoega H; Nassar N; Pearson SA, 2022, 'Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children', Paediatric and Perinatal Epidemiology, 36, pp. 726 - 737, http://dx.doi.org/10.1111/ppe.12870

Journal articles | 2022

Schaffer AL; Chia J; Brett J; Pearson S; Falster MO, 2022, 'A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia', Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 42, pp. 828 - 836, http://dx.doi.org/10.1002/phar.2735

Journal articles | 2022

Schaffer AL; Henry D; Zoega H; Elliott JH; Pearson SA, 2022, 'Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID- 19 pandemic in Australia', PLoS ONE, 17, pp. e0269482, http://dx.doi.org/10.1371/journal.pone.0269482

Journal articles | 2022

Tang M; Lee CK; Lewis CR; Boyer M; Brown B; Schaffer A; Pearson SA; Simes RJ, 2022, 'Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer', Lung Cancer, 166, pp. 40 - 48, http://dx.doi.org/10.1016/j.lungcan.2022.01.024

Journal articles | 2022

de Oliveira Costa J; Gillies MB; Schaffer AL; Peiris D; Zoega H; Pearson SA, 2022, 'Changes in antidepressant use in Australia: A nationwide analysis (2015–2021)', Australian and New Zealand Journal of Psychiatry, http://dx.doi.org/10.1177/00048674221079740

Journal articles | 2022

de Oliveira Costa J; Zhao Y; Pearson S; Schaffer A, 2022, 'Assessing the impact of implementing multiple adherence measures to antiretroviral therapy from dispensing data: a short report', AIDS Care: psychological and socio-medical aspects of AIDS-HIV, http://dx.doi.org/10.1080/09540121.2022.2050179

Journal articles | 2021

Daniels B; Pearson SA; Buckley NA; Bruno C; Schaffer A; Zoega H, 2021, 'Coming to grips with seemingly conflicting results in programme evaluation: The devil's in the detail', BMJ Quality and Safety, 30, pp. 70 - 71, http://dx.doi.org/10.1136/bmjqs-2020-012118

Journal articles | 2021

De Oliveira Costa J; Bruno C; Schaffer AL; Raichand S; Karanges EA; Pearson SA, 2021, 'The changing face of Australian data reforms: Impact on pharmacoepidemiology research', International Journal of Population Data Science, 6, http://dx.doi.org/10.23889/ijpds.v6i1.1418

Journal articles | 2021

Schaffer AL; Busingye D; Chidwick K; Brett J; Blogg S, 2021, 'Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study', BJGP Open, 5, pp. 1 - 10, http://dx.doi.org/10.3399/bjgpopen20X101120

Journal articles | 2021

Schaffer AL; Dobbins TA; Pearson SA, 2021, 'Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions', BMC Medical Research Methodology, 21, http://dx.doi.org/10.1186/s12874-021-01235-8

Journal articles | 2021

Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J, 2021, 'Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis', Clinical Pharmacology and Therapeutics, 109, pp. 212 - 221, http://dx.doi.org/10.1002/cpt.2113

Journal articles | 2021

Tang M; Daniels B; Aslam M; Schaffer A; Pearson SA, 2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', The Lancet Regional Health - Western Pacific, 14, http://dx.doi.org/10.1016/j.lanwpc.2021.100226

Journal articles | 2021

Tang M; Daniels B; Schaffer AL; Pearson SA, 2021, 'Real-world data to advance HER2-targeted cancer medicines research: Playing to the strengths of clinical registry and administrative data', Asia-Pacific Journal of Clinical Oncology, 17, pp. 414 - 415, http://dx.doi.org/10.1111/ajco.13554

Journal articles | 2021

Tang M; Pearson SA; Schaffer AL; Lewis CR; John T; Simes RJ; Lee CK, 2021, 'Are clinical trial eligibility criteria representative of older patients with lung cancer? A population-based data linkage study', Journal of Geriatric Oncology, 12, pp. 930 - 936, http://dx.doi.org/10.1016/j.jgo.2021.02.003

Journal articles | 2021

Tang M; Schaffer AL; Kiely BE; Daniels B; Lee CK; Simes RJ; Pearson SA, 2021, 'Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study', Breast Cancer Research and Treatment, 187, pp. 893 - 902, http://dx.doi.org/10.1007/s10549-021-06135-5

Journal articles | 2021

Tervonen HE; Schaffer AL; Luckett T; Phillips J; Litchfield M; Todd A; Pearson SA, 2021, 'Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 30, pp. 360 - 370, http://dx.doi.org/10.1002/pds.5081

Journal articles | 2021

Welberry HJ; Jorm LR; Schaffer AL; Barbieri S; Hsu B; Harris MF; Hall J; Brodaty H, 2021, 'Psychotropic medicine prescribing and polypharmacy for people with dementia entering residential aged care: the influence of changing general practitioners', Medical Journal of Australia, 215, pp. 130 - 136, http://dx.doi.org/10.5694/mja2.51153

Journal articles | 2020

Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H, 2020, 'Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia', BMJ Quality and Safety, 29, pp. 365 - 373, http://dx.doi.org/10.1136/bmjqs-2019-009897

Journal articles | 2020

Cairns R; Schaffer AL; Brown JA; Pearson SA; Buckley NA, 2020, 'Codeine use and harms in Australia: evaluating the effects of re-scheduling', Addiction, 115, pp. 451 - 459, http://dx.doi.org/10.1111/add.14798

Journal articles | 2020

Chitty KM; Schumann JL; Schaffer A; Cairns R; Gonzaga NJ; Raubenheimer JE; Carter G; Page A; Pearson SA; Buckley NA, 2020, 'Australian Suicide Prevention using Health-Linked Data (ASHLi): Protocol for a population-based case series study', BMJ Open, 10, pp. e038181, http://dx.doi.org/10.1136/bmjopen-2020-038181

Journal articles | 2020

Chiu T; Brett J; Pearson S; Schaffer A, 2020, 'Patterns of pregabalin initiation and discontinuation after its subsidy in Australia', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.14276

Journal articles | 2020

Cohen JM; Cesta CE; Furu K; Einarsdóttir K; Gissler M; Havard A; Hernandez-Diaz S; Huybrechts KF; Kieler H; Leinonen MK; Li J; Reutfors J; Schaffer A; Selmer R; Yu Y; Zoega H; Karlstad Ø, 2020, 'Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: A study in the five Nordic countries, United States, and Australia', Pharmacoepidemiology and Drug Safety, 29, pp. 913 - 922, http://dx.doi.org/10.1002/pds.5035

Journal articles | 2020

De Oliveira Costa J; Schaffer AL; Medland NA; Litchfield M; Narayan SW; Guy R; McManus H; Pearson SA, 2020, 'Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study', AIDS Patient Care and STDs, 34, pp. 81 - 91, http://dx.doi.org/10.1089/apc.2019.0278

Journal articles | 2020

Hsu B; Falster MO; Schaffer AL; Pearson S; Jorm L; Brieger DB, 2020, 'Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation', Medical Journal of Australia, 213, pp. 124 - 125, http://dx.doi.org/10.5694/mja2.50507

Journal articles | 2020

Reutfors J; Cesta CE; Cohen JM; Bateman BT; Brauer R; Einarsdóttir K; Engeland A; Furu K; Gissler M; Havard A; Hernandez-Diaz S; Huybrechts KF; Karlstad Ø; Leinonen MK; Li J; Man KKC; Pazzagli L; Schaffer A; Schink T; Wang Z; Yu Y; Zoega H; Bröms G, 2020, 'Antipsychotic drug use in pregnancy: A multinational study from ten countries', Schizophrenia Research, 220, pp. 106 - 115, http://dx.doi.org/10.1016/j.schres.2020.03.048

Journal articles | 2020

Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA, 2020, 'Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine', Medical Journal of Australia, 212, pp. 321 - 327, http://dx.doi.org/10.5694/mja2.50552

Journal articles | 2020

Schaffer AL; Pearson SA; Perez-Concha O; Dobbins T; Ward RL; Leeuwen MTV; Rhee JJ; Laaksonen MA; Craigen G; Vajdic CM, 2020, 'Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)', PLoS ONE, 15, pp. e0230373, http://dx.doi.org/10.1371/journal.pone.0230373

Journal articles | 2020

Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2020, 'Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016) (British Journal of Cancer, (2019), 121, 11, (904-911), 10.1038/s41416-019-0612-5)', British Journal of Cancer, 123, pp. 868, http://dx.doi.org/10.1038/s41416-020-0908-5

Journal articles | 2020

Zheng D; Brett J; Daniels B; Buckley NA; Pearson SA; Schaffer AL, 2020, 'Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014–2017)', Drug and Alcohol Review, 39, pp. 575 - 582, http://dx.doi.org/10.1111/dar.13086

Journal articles | 2019

Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA, 2019, 'Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)—in reply', Addiction, 114, pp. 572 - 573, http://dx.doi.org/10.1111/add.14531

Journal articles | 2019

Han D; Narayan SW; Zoega H; Litchfield M; Buckley NA; Pearson SA; Schaffer AL, 2019, 'Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate', Pharmacoepidemiology and Drug Safety, 28, pp. 521 - 527, http://dx.doi.org/10.1002/pds.4755

Journal articles | 2019

Schaffer AL; Buckley NA; Cairns R; Pearson S, 2019, 'Comparison of Prescribing Patterns before and after Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia', JAMA Network Open, 2, pp. e1911590, http://dx.doi.org/10.1001/jamanetworkopen.2019.11590

Journal articles | 2019

Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A, 2019, 'Evidence-practice gaps in postdischarge initiation with oral anticoagulants in patients with atrial fibrillation', Journal of the American Heart Association, 8, pp. e014287, http://dx.doi.org/10.1161/JAHA.119.014287

Journal articles | 2019

Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA, 2019, 'Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study', Pharmacoepidemiology and Drug Safety, 28, pp. 97 - 105, http://dx.doi.org/10.1002/pds.4683

Journal articles | 2019

Schaffer AL; Zoega H; Tran DT; Buckley NA; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics', Australian & New Zealand Journal of Psychiatry, pp. 000486741984776 - 000486741984776, http://dx.doi.org/10.1177/0004867419847764

Journal articles | 2019

Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2019, 'Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)', British Journal of Cancer, 121, pp. 904 - 911, http://dx.doi.org/10.1038/s41416-019-0612-5

Journal articles | 2019

Tang M; Schaffer A; Pearson SA, 2019, 'Embracing the full spectrum of real-world data for cancer medicines research in Australia', Asia-Pacific Journal of Clinical Oncology, 15, pp. 186 - 187, http://dx.doi.org/10.1111/ajco.13121

Journal articles | 2019

Vajdic CM; Perez-Concha O; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, 60, pp. 156 - 161, http://dx.doi.org/10.1016/j.canep.2019.04.004

Journal articles | 2019

Vajdic CM; Perez-Concha O; Rhee JJ; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, 61, pp. 1 - 7, http://dx.doi.org/10.1016/j.canep.2019.05.001

Journal articles | 2018

Brett J; Schaffer A; Dobbins T; Buckley NA; Pearson SA, 2018, 'The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 27, pp. 439 - 446, http://dx.doi.org/10.1002/pds.4408

Journal articles | 2018

Cairns R; Schaffer A; Ryan N; Pearson S; Buckley NA, 2018, 'Rising pregabalin use and misuse in Australia: trends in utilisation and intentional poisonings', Addiction, http://dx.doi.org/10.1111/add.14412

Journal articles | 2018

Morgan A; Joshy G; Schaffer A; Laba T-L; Litchfield M; Pearson S; Banks E, 2018, 'Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants', PLoS ONE, 13, pp. e0208824, http://dx.doi.org/10.1371/journal.pone.0208824

Journal articles | 2018

Schaffer A; Buckley NA; Degenhardt L; Larance B; Cairns R; Dobbins T; Pearson SA, 2018, 'Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia', Canadian Medical Association Journal, 190, pp. E355 - E362, http://dx.doi.org/10.1503/cmaj.170666

Journal articles | 2017

Joshi V; Adelstein BA; Schaffer A; Srasuebkul P; Dobbins T; Pearson SA, 2017, 'Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data', Asia-Pacific Journal of Clinical Oncology, 13, pp. e246 - e252, http://dx.doi.org/10.1111/ajco.12602

Journal articles | 2017

Schaffer AL; Buckley NA; Pearson SA, 2017, 'Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy', Pharmacoepidemiology and Drug Safety, 26, pp. 1465 - 1473, http://dx.doi.org/10.1002/pds.4342

Journal articles | 2016

Schaffer AL; Buckley NA; Cairns R; Pearson SA, 2016, 'Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: Taking control of prescription drug use', JAMA Internal Medicine, 176, pp. 1223 - 1225, http://dx.doi.org/10.1001/jamainternmed.2016.2992

Journal articles | 2016

Schaffer AL; Pearson SA; Buckley NA, 2016, 'How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006–2014)', British Journal of Clinical Pharmacology, pp. 1134 - 1145, http://dx.doi.org/10.1111/bcp.13043

Journal articles | 2015

Gnjidic D; Pearson SA; Hilmer SN; Basilakis J; Schaffer AL; Blyth FM; Banks E, 2015, 'Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: A validation study', Public Health Research and Practice, 25, http://dx.doi.org/10.17061/phrp2521518

Journal articles | 2015

Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA, 2015, 'The Australian Pharmaceutical Benefits Scheme data collection: A practical guide for researchers', BMC Research Notes, 8, http://dx.doi.org/10.1186/s13104-015-1616-8

Journal articles | 2015

Schaffer AL; Buckley NA; Dobbins TA; Banks E; Pearson SA, 2015, 'The crux of the matter: Did the ABC’s catalyst program change Statin use in Australia?', Medical Journal of Australia, 202, pp. 591 - 595, http://dx.doi.org/10.5694/mja15.00103

Journal articles | 2015

Schaffer AL; Pearson SA; Dobbins TA; Er CC; Ward RL; Vajdic CM, 2015, 'Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients', Cancer Epidemiology, 39, pp. 578 - 584, http://dx.doi.org/10.1016/j.canep.2015.02.007

Journal articles | 2015

Vajdic CM; Ward RL, 2015, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs client', Cancer Epidemiology, 39, pp. 585 - 592, http://dx.doi.org/10.1016/j.canep.2015.02.006

Journal articles | 2014

Ganda K; Schaffer A; Pearson S; Seibel MJ, 2014, 'Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: A randomised controlled trial of specialist vs. non-specialist management', Osteoporosis International, 25, pp. 1345 - 1355, http://dx.doi.org/10.1007/s00198-013-2610-4

Journal articles | 2014

Ganda K; Schaffer A; Seibel MJ, 2014, 'Predictors of re-fracture amongst patients managed within a secondary fracture prevention program: a 7-year prospective study', Osteoporosis International, 26, pp. 543 - 551, http://dx.doi.org/10.1007/s00198-014-2880-5

Journal articles | 2014

Pearson SA; Schaffer A, 2014, 'The use and impact of cancer medicines in routine clinical care: Methods and observations in a cohort of elderly Australians', BMJ Open, 4, http://dx.doi.org/10.1136/bmjopen-2013-004099

Journal articles | 2014

Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA, 2014, 'An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data', Cancer Epidemiology, 38, pp. 460 - 464, http://dx.doi.org/10.1016/j.canep.2014.05.004

Journal articles | 2013

Joshi V; Adelstein B-A; Schaffer A; Srasuebkul P; Dobbins T; Pearson S-A, 2013, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 221 - 222, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Journal articles | 2012

Schaffer A; Muscatello D; Broome R; Corbett S; Smith W, 2012, 'Emergency department visits, ambulance calls, and mortality associated with an exceptional heat wave in Sydney, Australia, 2011: A time-series analysis', Environmental Health: A Global Access Science Source, 11, http://dx.doi.org/10.1186/1476-069X-11-3

Journal articles | 2012

Schaffer A; Muscatello D; Cretikos M; Gilmour R; Tobin S; Ward J, 2012, 'The impact of influenza A(H1N1)pdm09 compared with seasonal influenza on intensive care admissions in New South Wales, Australia, 2007 to 2010: A time series analysis', BMC Public Health, 12, http://dx.doi.org/10.1186/1471-2458-12-869

Journal articles | 2007

Brotherton J; Wang H; Schaffer A; Quinn H; Menzies R; Hull B; Lawrence GL; Wood J; Wood N; Rosewell A; Newall AT; MacIntyre CR; Macartney K; Gidding HF; McIntyre P; Booy R, 2007, 'Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 31, pp. S1 - S152

Journal articles | 2007

Schaffer A; Brotherton J; Booy R, 2007, 'Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children?', Journal of Paediatrics and Child Health, 43, pp. 579 - 580, http://dx.doi.org/10.1111/j.1440-1754.2007.01205.x

Journal articles | 2007

Schaffer A; Koushik A; Trottier H; Duarte-Franco E; Mansour N; Arseneau J; Provencher D; Gilbert L; Gotlieb W; Ferenczy A; Coutlée F; Pollak MN; Franco EL; Matlashewski G; Roger M; Piché S; Capek A; Juras A; Michon B; Florakas C; Landry D; Grandmont D; L'Heureux D; Dalton D; Queiros E; Dauth E; Leclerc F; Stanimir G; Hum HS; Czitrom JP; Dubuc-Lissoir J; Lord J; Mayrand MH; Dupuis MJ; Martin M; Roleau M; Plamondon M; Fournier P; Gauthier P; Drouin P; Fournier P; Jeanbart P; Shatz R; Piché R; Hunt R, 2007, 'Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia', Cancer Epidemiology Biomarkers and Prevention, 16, pp. 716 - 722, http://dx.doi.org/10.1158/1055-9965.EPI-06-0924
Preprints | 2023

The OpenSAFELY Collaborative ; Brown A; Fisher L; Curtis H; Wiedemann M; Hulme W; Hopcroft LEM; Cunningham C; Speed V; Costello R; Galloway J; Russell M; Bechman K; Kurt Z; Croker R; Wood C; Walker A; Schaffer A; Bacon SCJ; Mehrkar A; Hickman G; Bates C; Cockburn J; Parry J; Hester F; Harper S; Goldacre B; MacKenna B, 2023, OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rate, , http://dx.doi.org/10.1101/2023.06.06.23290826

Preprints | 2023

The OpenSAFELY Collaborative ; Schaffer A; Park R; Tazare J; Bhaskaran K; MacKenna B; Denaxas S; Dillingham I; Bacon SCJ; Mehrkar A; Bates C; Goldacre B; Greaves F; Macleod J; Tomlinson L; Walker A; National Core Studies Collaborative , 2023, Fit notes associated with COVID-19 in 24 million patients’ primary care records: A cohort study in OpenSAFELY-TPP, , http://dx.doi.org/10.1101/2023.07.28.23293269

Preprints | 2023

The OpenSAFELY Collaborative ; Wood C; Speed V; Fisher L; Curtis H; Schaffer A; Walker A; Croker R; Brown A; Cunningham C; Hulme W; Andrews C; Butler-Cole BFC; Evans D; Inglesby P; Dillingham I; Bacon SCJ; Davy S; Ward T; Hickman G; Bridges L; O’Dwyer T; Maude S; Smith R; Mehrkar A; Bates C; Cockburn J; Parry J; Hester F; Harper S; Goldacre B; MacKenna B, 2023, The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records, , http://dx.doi.org/10.1101/2023.07.31.23293419

Preprints | 2023

The OpenSAFELY collaborative ; Tazare J; Nab L; Zheng B; Hulme W; Green A; Curtis H; Mahalingasivam V; Higgins R; Schultze A; Bhaskaran K; Mehrkar A; Schaffer A; Smith R; Bates C; Cockburn J; Parry J; Hester F; Harper S; Eggo R; Walker A; Marks M; Brown M; Maringe C; Leyrat C; Evans S; Goldacre B; MacKenna B; Sterne J; Tomlinson L; Douglas I, 2023, Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform, , http://dx.doi.org/10.1101/2023.05.12.23289914

Conference Abstracts | 2022

Camacho X; Schaffer A; Buckley NA; Pratt N; Henry D; Pearson S-A, 2022, 'Trends in dispensing and utilization of tapentadol in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 543 - 544, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084402283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2022

Chitty K; Buckley N; Lim J; Ali Z; Schumann J; Cairns R; Daniels B; Preen D; Schaffer A, 2022, 'An overview of psychotropic pharmacotherapy at time of death by suicide: An Australian-wide case series study using administrative and coronial data', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084400137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2022

Gisev N; Buizen L; Schaffer A; Daniels B; Pearson S-A; Dobbins T; Blyth F; Larney S; Currow DC; Wilson A; Degenhardt L, 2022, '| New South Wales, Long-term trajectories of prescription opioid use in New South Wales, Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 371 - 372, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084401349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2022

Schaffer A; Buckley NA; Schumann J; Lim J; Cairns R; Chitty K, 2022, 'Patterns of psychotropic medicine use and initiation in the year prior to death by suicide: A population-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 366 - 366, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084401338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2022

Schaffer AL; Brett J; Buckley NA; Pearson SA, 2022, 'Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use', in Pain, LIPPINCOTT WILLIAMS & WILKINS, United States, Vol. 163, pp. E614 - E621, United States, http://dx.doi.org/10.1097/j.pain.0000000000002433

Conference Papers | 2022

Tang M; Lee C; Lewis C; Boyer M; Brown B; Schaffer A; Pearson S-A; Simes R, 2022, 'Immune checkpoint inhibitors in advanced non-small cell lung cancer: Real-world survival and safety', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 30 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000879941200025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2021

Cohen J; Alvestad S; Suarez E; Schaffer A; Selmer R; Havard A; Bateman B; Zoega H; Kieler H; Odsbu I; Huybrechts K; Kjerpeseth L; Straub L; Leinonen M; Bjork M-H; Norgaard M; Gissler M; Ulrichsen S; Hernandez-Diaz S; Tomson T; Furu K, 2021, 'The Comparative Safety of Antiseizure Medication Polytherapy vs Valproate in Pregnancy and Risk of Major Congenital Malformations', in Pharmacoepidemiology and Drug Safety, John Wiley and Sons, Virtual, presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021

Conference Abstracts | 2021

Daniels B; Pearson S-A; Bruno C; Buckley N; Schaffer A; Jun M; Zoega H, 2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300446&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations | 2021

Schaffer A; Brett J; Buckley N; Pearson S, 2021, 'Trajectories of Pregabalin Use and Their Association with Longitudinal Changes in Opioid and Benzodiazepine Daily Dose', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021

Preprints | 2021

Schaffer A; Henry D; Zoega H; Elliott J; Pearson S-A, 2021, Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia, , http://dx.doi.org/10.1101/2021.09.26.21264150

Conference Presentations | 2021

Schaffer A; Nassar N; Bruno C; Buckley N; Cairns R; Litchfield M; Paget S; Zoega H; Pearson S, 2021, 'Prescribed Medicine Use in a Nationwide Sample of Australian Children: Extent of Off-Label Use', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021

Conference Papers | 2021

Tang M; Daniels B; Aslam M; Schaffer AL; Pearson S-A, 2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 69 - 70, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2021

Tang M; Schaffer A; Kiely B; Daniels B; Lee C; Simes J; Pearson S-A, 2021, 'Cardiac assessment in Australian patients receiving trastuzumab for HER2+early breast cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2021

Welberry H; Jorm L; Schaffer A; Barbieri S; Hsu B; Harris M; Hall J; Brodaty H, 2021, 'Changing general practitioner when entering residential aged care: impact on psychotropic medicine use and polypharmacy in 2,250 Australians with dementia', in Australian Dementia Forum, presented at Australian Dementia Forum

Preprints | 2021

de Oliveira Costa J; Gillies M; Schaffer A; Peiris D; Zoega H; Pearson S-A, 2021, Changes in antidepressant use in Australia: A nationwide analysis prior to and during the COVID-19 pandemic (2015-2021), , http://dx.doi.org/10.1101/2021.11.24.21266837

Conference Presentations | 2020

Carland J; Stocker S; Reuter S; Stacy A; Schaffer A; Stefani M; Lau C; Kirubakaran R; Yang J; Shen C; Roberts D; Marriott D; Day R; Brett J, 2020, 'Evaluation of a pilot vancomycin therapeutic drug monitoring (TDM) service using an interrupted time series analysis', presented at ASCEPT, Virtual, 29 November 2020 - 02 December 2020

Conference Presentations | 2020

Schaffer A; Cairns R; Brown J; Gisev N; Buckley N; Pearson S, 2020, 'Changes in sales of over‐the‐counter and prescription medicines after rescheduling of codeine to a prescription‐only medicine in Australia', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Conference Papers | 2020

Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson S-A, 2020, 'Changes in sales of over-the-counter and prescription medicines after rescheduling of codeine to a prescription-only medicine in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 142 - 142, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2019

Chiu T; Pearson S; Schaffer A, 2019, 'Pregabalin use outside subsidy restrictions in Australia', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864

Conference Presentations | 2019

Schaffer A; Buckley N; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', presented at International Conference on Pharmacoepidemiology and Drug Safety, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864

Conference Papers | 2019

Schaffer A; Zoega H; Tran DT; Buckley N; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and related maternal and birth characteristics', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864

Conference Abstracts | 2019

Schaffer AL; Buckley NA; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 34 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785600063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2019

Vajdic CM; Perez-Concha O; Rhee J; Dobbins T; Ward R; Schaffer A; Van Leeuwen MT; Laaksonen M; Craigen G; Pearson S, 2019, 'Risk factors for cancer registry-notified cancer of unknown primary site (CUP)', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide, Vol. 15, pp. 84 - 85, presented at Clinical Oncology Society of Australia 46th Annual Scientific Meeting, Adelaide, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13262

Conference Abstracts | 2018

Brieger D; Falster M; Schaffer A; Jorm L; Pearson S; Emerson L; Hay M; Nasis A; Wilson A, 2018, 'P2Y12 Inhibitor Therapy is Underutilised in Patients Hospitalised for Acute Myocardial Infarction: Results From a New Population-Level Data Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Brisbane, Australia, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Brisbane, Australia

Conference Abstracts | 2018

Falster M; Schaffer A; Jorm L; Wilson A; Brieger D; Nasis A; Emerson L; Pearson S, 2018, 'Using Australia’s National Data Linkage Demonstration Project (NDLDP) to improve cardiac care: Towards a national, whole-of-population linked data resource for evidence-informed health policy', in International Journal of Population Data Science, Swansea University, Banff, Canada, presented at International Population Data Linkage Conference 2018, Banff, Canada, http://dx.doi.org/10.23889/ijpds.v3i4.640

Conference Abstracts | 2018

Nasis A; Schaffer A; Falster M; Pearson S; Jorm L; Emerson L; Hay M; Brieger D; Wilson A, 2018, 'Use of Oral Anticoagulants After Hospital Discharge in Patients With Atrial Fibrillation: Insights From a New Population-Level Linkage in Australia', in Heart, Lung and Circulation, Elsevier, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand

Conference Abstracts | 2018

Reutfors J; Zoega H; Cesta C; Bateman BT; Cantarutti A; Cohen J; Corrao G; Einarsdottir K; Engeland A; Furu K; Havard A; Hernandez-Diaz S; Huybrechts KF; Karlsson P; Karlstad O; Li J; Schaffer A; Yu Y; Broms G, 2018, 'Antipsychotic drug use in pregnancy: A multinational database study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 235 - 235, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893802059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports | 2018

Schaffer A; Falster M; Pearson S; Jorm L; Wilson A; Nasis A; Brieger D, 2018, Delivering better cardiac outcomes: Primary, specialist and hospital care

Conference Presentations | 2017

Schaffer AL; Buckley NA; Dobbins T; Degenhardt L; Larance B; Pearson SA, 2017, 'Opioid Switching After Introduction of a Tamper-Resistant Oxycodone Formulation in Australia: A Population-Based Study', presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017, http://dx.doi.org/10.1002/pds.4275

Conference Presentations | 2017

Schaffer AL; Buckley NA; Dobbins TA; Degenhardt L; Larance B; Pearson S-A, 2017, 'Opioid Switching After Introduction of a Tamper-Resistant Oxycodone Formulation in Australia: A Population-Based Study', Vol. 26, pp. 212 - 212, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437103900349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2017

Schaffer AL; Buckley NA; Pearson S, 2017, 'Two-Year Statin Adherence Trajectories in Initiators of Combined Amlodipine-Atorvastatin Therapy: A Population-Based Study (2005–2015)', in Abstracts of the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, WILEY, Montreal, Canada, Vol. 26, pp. 519 - 520, presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017, http://dx.doi.org/10.1002/pds.4275

Reports | 2017

Zoega H; Schaffer A; Litchfield M; Pearson S, 2017, Post-market Review - Pulmonary Arterial Hypertension Medicines

Conference Papers | 2016

Schaffer AL; Pearson S-A; Buckley NA, 2016, 'Does Concordance with Fixed-Dose Combination (FDC) Treatment Guidelines Improve Persistence? An Australian Population Based Cohort Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 292 - 292, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483502132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters | 2016

Schaffer AL; buckley N; cairns R; pearson S, 2016, 'Up-Scheduling of Alprazolam to a “Controlled Drug”: Interrupted Time Series Analysis of Its Impact on Benzodiazepine (BZD) Prescribing, Dispensing and Poisonings in Australia.', Dublin, Ireland, Vol. 25, pp. 346 - 347, presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.4070

Conference Presentations | 2016

Schaffer AL; pearson S; buckley N, 2016, 'Does Concordance with Fixed-Dose Combination (FDC) Treatment Guidelines Improve Persistence? An Australian Population Based Cohort Study.', Vol. 25 Suppl 3, pp. 3 - 679, presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.4070

Conference Presentations | 2016

joshi V; adelstein BA; Schaffer AL; srasuebkul P; EoCC Investigators ; dobbins T; pearson S, 2016, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', Vol. 22, presented at 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.3512

Conference Presentations | 2015

Schaffer AL; Buckley NA; Dobbins T; Banks E; Pearson S-A, 2015, 'Time Series Analysis of the Impact of Adverse Media on Statin Dispensing and Discontinuation in Australia', Vol. 24, pp. 237 - 238, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369980200411&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations | 2014

Vajdic CM; Schaffer A; Dobbins TA; Barrett J; Ward RL; Er CC; Pearson S-A, 2014, 'HEALTH SERVICE UTILISATION AND INVESTIGATIONS BEFORE DIAGNOSIS OF CANCER OF UNKNOWN PRIMARY (CUP): A POPULATION-BASED NESTED CASE-CONTROL STUDY', Vol. 10, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations | 2014

Vajdic CM; Schaffer A; Dobbins TA; Ward RL; Barrett J; Er CC; Pearson S-A, 2014, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study', Vol. 10, pp. 203 - 203, presented at 2014 World Cancer Congress, Melbourne, 03 December 2014 - 06 December 2014, http://dx.doi.org/10.1111/ajco.12332

Conference Papers | 2013

Ganda K; Seibel M; Schaffer A; Pearson S, 2013, 'Adherence to Oral Bisphosphonate Therapy in a Fracture Liaison Service: A Randomised Controlled Trial', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY-BLACKWELL, MD, Baltimore, presented at Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, MD, Baltimore, 04 October 2013 - 07 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332035804007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations | 2013

Schaffer AL; Pearson S-A; Dobbins T; Er C; Meagher NS; Barrett J; Ward RL; Vajdic CM, 2013, 'HEALTH SERVICE USE, TREATMENT PATTERNS, AND SURVIVAL FOR CANCER OF UNKNOWN PRIMARY: A DATA LINKAGE STUDY', Vol. 9, pp. 98 - 98, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations | 2011

Schaffer AL; muscatello D; broome R; corbett S; smith W, 2011, 'Excess hospital admissions, ambulance calls and mortality during an exceptional heat wave in February 2011.', Vol. 18, presented at Australasian Epidemiological Association Annual Scientific Meeting, Perth, Australia

Conference Presentations | 2010

Schaffer AL; levi C; moore H; rose N; gattelari M; worthington J, 2010, 'Use of linked hospital data to assess the impact of the introduction of tissue plasminogen activator (tPA) therapy on stroke outcomes in NSW.', Vol. 17, presented at Australasian Epidemiological Association 17th Annual Scientific Meeting, Sydney, Australia

NHMRC-EU Collaborative Research Grant (CIC, 2021-2023) - "ManagemenT of chronIc cardioMetabolic diseasE and treatment diScontinuity in adult ADHD PAtieNts (TIMESPAN)"

NHMRC Ideas Grant (CIA, 2021-2023) - "Disentangling the interrelationship between multimorbidity, multimedicine use, and cardiovascular health"

NHMRC Project Grant (CIC, 2019-2022) - "Health service and medicine utilisation before suicide: optimising suicide prevention using population-based linkage of routinely collected data"

NHMRC Early Career Fellowship (2019-2022) - "Evaluating population-level medicine policy interventions: generating high-quality evidence about intended and unintended consequences"

NHMRC Post-graduate scholarship (2014-2017)

2019 - UNSW Medicine Early Career Academic Network (ECAN) Best Paper Award, Clinical, Health Services or Public Health category

2019 - Best Paper by an Early Career Researcher (Highly Commended) at the 11th Health Services and Research Association of Australian and New Zealand

2017 - Rising Star Award for best abstract presented by a junior investigator at the 10th Asian Conference on Pharmacoepidemiology

2016 - MJA, MDA National Prize for Excellence in Medical Research for best clinical paper published in the Medical Journal of Australia in 2015

2015 - Stanley A. Edlavitch award for best abstract submitted by a student to the 31st International Conference on Pharmacoepidemiology

Dr Andrea Schaffer

Follow me